REQUEST A DEMO
Total
USD $0.00
Search more companies

Kevipharma Laboratorio Farmaceutico Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing
Full name: Kevipharma Laboratorio Farmaceutico Sas Profile Updated: August 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Kevipharma Laboratorio Farmaceutico Sas is based in Colombia. The head office is in Cali. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on September 05, 2006. There are currently 2 (2024) people employed by Kevipharma Laboratorio Farmaceutico Sas. From the latest financial highlights, Kevipharma Laboratorio Farmaceutico Sas reported a net sales revenue drop of 25.82% in 2023. Its’ total assets recorded a negative growth of 26.05%. In 2023, Kevipharma Laboratorio Farmaceutico Sas’s net profit margin increased by 1.8%.

Headquarters
Cra 29A1 10A 85 Barrio Colseguros Andes
Cali; Valle del Cauca;

Contact Details: Purchase the Kevipharma Laboratorio Farmaceutico Sas report to view the information.

Basic Information
Total Employees:
Purchase the Kevipharma Laboratorio Farmaceutico Sas report to view the information.
Outstanding Shares:
Purchase the Kevipharma Laboratorio Farmaceutico Sas report to view the information.
Incorporation Date:
September 05, 2006
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Kevipharma Laboratorio Farmaceutico Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-25.82%
Total operating revenue
-25.82%
Operating profit (EBIT)
471.46%
Net Profit (Loss) for the Period
12.85%
Total assets
-26.05%
Total equity
5.52%
Operating Profit Margin (ROS)
23.16%
Net Profit Margin
1.8%
Return on Equity (ROE)
0.96%
Quick Ratio
-0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?